IBM's Story: From 'No-Growth Company' to Two Guidance Raises — Then the First Crack

The story

Late 2023: still recovering, still cautious

On the Q3 FY2023 call, IBM management repeated careful, familiar lines — "constant-currency revenue growth of 3-5%, and about $10.5 billion in free cash flow" — and described software revenue as merely at "the high end of its mid-single-digit model," a hedged phrasing for a company still healing from two big surgeries: the 2021 Kyndryl spinoff and the 2019 Red Hat acquisition. That year's 10-K still carried a standalone risk factor warning the Kyndryl spinoff could trigger a substantial tax liability if it failed to qualify for tax-free treatment.

Q3 FY2024: the CFO declares the turnaround complete

On the Q3 FY2024 call, the mood shifted decisively. The CFO looked back over three years and said flatly: "three years ago, Arvind transformed this company from a no-growth company into a mid-single-digit growth company," with pre-tax margin "up 700 to 800 basis points... into the high teens." That same quarter's 10-K added a brand-new standalone risk factor mentioning "generative AI" six times ("The Development and Use of AI and Generative AI..."), while the Kyndryl tax risk factor — present in every 10-K since 2021 — disappeared entirely (8 mentions down to 0). Old scar tissue was removed and a new growth narrative installed in the same filing cycle.

Guidance kept climbing — with one real wobble

From there, guidance rose twice: the Q4 FY2024 call set 2025 targets at "5%+ revenue growth, about $13 billion FCF," and the Q3 FY2025 call raised that again to "5%+ revenue growth, about $14 billion FCF." Actual FY2025 results beat even the raised targets (+6% constant-currency revenue, $14.7 billion FCF). There was a genuine wobble in between: on the Q2 FY2025 call, management admitted being "prudently cautious" about consulting's growth contribution, and acknowledged software growth had run 2 percentage points below its own internal model.

Q2 FY2026: the first real crack

The tone shifted more sharply this time. Management attributed the quarter's software softness specifically to "capital-expenditure-sensitive areas," saying "dozens of large deals didn't close when expected," and cut annual software growth guidance to 6-8%. On the call, analyst Amit Daryanani asked directly whether the softness reflected customers reallocating IT budgets toward AI infrastructure rather than cutting spending outright. CEO Arvind Krishna's response stayed largely general — confidence in the portfolio and growth opportunities — without a specific rebuttal. Company-wide revenue guidance (5%+) held, but this was the first quarter where one of IBM's core pillars visibly stumbled.

Guidance scorecard

FCF targets: 3 for 3 across confirmed fiscal years. Revenue growth targets: 2 for 3, with FY2024 the clear miss. The pattern is a conservative FCF guide that IBM consistently clears — until Q2 FY2026 became the first quarter with a segment-specific guidance cut rather than a full-year miss or beat.

Source: IBM Q3 FY2023 through Q2 FY2026 earnings call transcripts (guidance language) and IBM's quarterly/annual earnings press releases (Ex-99.1).

Timeline

• Q3 2023Still recovering from the Kyndryl spinoff and Red Hat acquisition; guidance cautiously reaffirmed.
• Q3 2024CFO publicly declares the 3-year "no-growth to growth" turnaround complete; the tone-inflection point of the series.
• FY2024 10-KNew standalone generative-AI risk factor added; the Kyndryl tax risk factor is removed. Filing language swaps "past" for "AI."
• Q2 2025"Prudently cautious" language appears around consulting; software growth runs 2 points below IBM's own model.
• Q3 2025Second guidance raise of the year (5%+ revenue, $14B FCF); the highest confidence point of the whole 3-year run.
• Q2 2026Large-deal delays cause a software revenue shortfall; segment guidance cut to 6-8%; an analyst directly asks about AI-driven budget reallocation.

Our read

IBM's last three years trace a genuine turnaround, publicly declared complete by its own CFO and then validated by results that beat a guidance range raised twice in a single year. Q2 FY2026 is the first real wrinkle in that story — not a company-wide miss, but a segment-specific one, arriving with a plausible and unresolved explanation on the table: that the same AI spending boom driving IBM's growth narrative could also be quietly redirecting customer budgets away from IBM's other lines. The company's own guidance still holds company-wide, which argues for patience over alarm, but this is a thread worth pulling on in the next couple of quarters.

What we still don't know

• Whether Q2 FY2026's software softness was a temporary large-deal delay or a structural shift — if it's truly deferred revenue, it should show up in Q3 FY2026 results; that quarter's earnings call would need to be checked.
• Whether the analyst's "AI infrastructure budget reallocation" hypothesis is actually correct — management's answer stayed general, and no concrete rebuttal data was disclosed in the call reviewed.
• The background behind the 2024 General Counsel replacement (Michelle Browdy to Anne Robinson) isn't explained in the 10-K or DEF 14A.
• The reliability of the Q2 FY2024 tone score is lower than other quarters — no distinct signal was found in that quarter's call, so it was scored the same as the surrounding quarters rather than independently assessed.